BRAF and neoplasm: When the impact on tumor relapse was evaluated in the 19 PTC patients without DMs, the probability of tumor recurrence appeared significantly associated with the presence of BRAF mutations and the coexistence of BRAF mutations and TPM (Log-rank P = 0.0087 and Log-rank P = 0.0282, respectively) (“Online resource – Figure-1”).